$EYEN
EYENOVIA, INC. Stock $eyen

$eyen Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000141057823000511 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cost Of Revenue		$0.00	$0.00
YoY Change			-100.0%
Gross Profit		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Gross Profit Margin
Selling, General & Admin	$2.940M	$3.170M	$13.60M
YoY Change	-15.39%	-14.59%	26.07%
% of Gross Profit
Research & Development	$2.522M	$2.282M	$13.38M
YoY Change	-32.07%	-28.15%	-7.79%
% of Gross Profit
Depreciation & Amortization	$63.12K	$78.53K	$307.4K
YoY Change	-16.32%	7.12%	38.76%
% of Gross Profit
Operating Expenses	$5.459M	$5.372M	$26.91M
YoY Change	-24.05%	-21.99%	6.35%
Operating Profit	-$5.459M	-$5.372M	-$26.91M
YoY Change	-24.05%	-272.56%	108.56%
Interest Expense	$454.0K	-$851.6K	$1.380M
YoY Change	212.59%	359.87%	255.91%
% of Operating Profit
Other Income/Expense, Net	$70.99K	$100.5K	$197.1K
YoY Change	-1103.72%	82.12%	317.71%
Pretax Income	-$5.740M	-$6.123M	-$28.01M
YoY Change	-21.79%	-305.26%	119.21%
Income Tax
% Of Pretax Income
Net Earnings	-$5.739M	-$6.123M	-$28.01M
YoY Change	-21.8%	-305.26%	118.84%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.15		-$0.83
Diluted Earnings Per Share	-$0.15	-$0.17	-$0.83
COMMON SHARES
Basic Shares Outstanding	37.99M	36.11M	33.65M
Diluted Shares Outstanding	37.41M		33.65M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.59M	$22.98M	$22.98M
YoY Change	-30.43%	18.09%	18.09%
Cash & Equivalents	$18.50M	$22.90M
Short-Term Investments	$119.6K	$119.6K	$119.6K
Other Short-Term Assets	$4.719M	$2.815M	$2.815M
YoY Change	157.85%	-65.95%	-65.95%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$24.92M	$27.64M	$27.64M
YoY Change	-18.01%	25.71%	-7.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.153M	$1.295M	$2.587M
YoY Change	57.1%	1.88%	103.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$80.87K	$80.87K	$80.87K
YoY Change	-32.06%
Other Assets	$643.5K	$726.3K	$726.3K
YoY Change	-92.36%	42.14%	42.14%
Total Long-Term Assets	$4.385M	$3.394M	$3.394M
YoY Change	-55.2%	-64.91%	90.43%
TOTAL ASSETS
Total Short-Term Assets	$24.92M	$27.64M	$27.64M
Total Long-Term Assets	$4.385M	$3.394M	$3.394M
Total Assets	$29.31M	$31.04M	$31.04M
YoY Change	-27.07%	-1.97%	-1.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.402M	$1.428M	$1.428M
YoY Change	-8.65%	-11.51%	-11.51%
Accrued Expenses	$1.523M	$2.680M	$2.680M
YoY Change	44.09%	15.18%	15.18%
Deferred Revenue
YoY Change
Short-Term Debt	$709.9K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.219M	$348.9K	$348.9K
YoY Change	-84.25%	-95.12%	-95.12%
Total Short-Term Liabilities	$4.901M	$4.512M	$4.512M
YoY Change	-52.78%	-59.61%	-59.61%
LONG-TERM LIABILITIES
Long-Term Debt	$7.461M	$8.382M	$8.382M
YoY Change
Other Long-Term Liabilities	$1.134M	$907.6K	$907.6K
YoY Change	7419.56%	4449.57%	4449.57%
Total Long-Term Liabilities	$8.595M	$9.290M	$9.290M
YoY Change	56892.77%	46464.01%	46464.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.901M	$4.512M	$4.512M
Total Long-Term Liabilities	$8.595M	$9.290M	$9.290M
Total Liabilities	$13.50M	$13.80M	$13.80M
YoY Change	29.84%	23.31%	23.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$124.0M	-$118.2M
YoY Change	27.02%	31.01%
Common Stock	$3.799K	$3.667K
YoY Change	19.8%	28.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$15.91M	$0.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.81M	$17.23M	$17.23M
YoY Change
Total Liabilities & Shareholders Equity	$29.31M	$31.04M	$31.04M
YoY Change	-27.07%	-1.97%	-1.97%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$5.739M	-$6.123M	-$28.01M
YoY Change	-21.8%	-305.26%	118.84%
Depreciation, Depletion And Amortization	$63.12K	$78.53K	$307.4K
YoY Change	-16.32%	7.12%	38.76%
Cash From Operating Activities	-$7.000M	-$5.405M	-$25.10M
YoY Change	-14.63%	-8.03%	20.1%
INVESTING ACTIVITIES
Capital Expenditures	$920.9K	$30.99K	$540.4K
YoY Change	427.51%	-150.38%	-55.95%
Acquisitions
YoY Change
Other Investing Activities	$82.81K	-$280.8K	-$334.4K
YoY Change	-350.18%	-28.36%	-14.68%
Cash From Investing Activities	-$838.1K	-$311.8K	-$874.7K
YoY Change	303.57%	-31.24%	-45.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$8.025M
YoY Change
Cash From Financing Activities	3.400M	3.307M	21.51M
YoY Change	-78.27%	-73.1%	0.23%
NET CHANGE
Cash From Operating Activities	-7.000M	-5.405M	-25.10M
Cash From Investing Activities	-838.1K	-311.8K	-874.7K
Cash From Financing Activities	3.400M	3.307M	21.51M
Net Change In Cash	-4.397M	-2.410M	-4.473M
YoY Change	-160.61%	-140.43%	332.21%
FREE CASH FLOW
Cash From Operating Activities	-$7.000M	-$5.405M	-$25.10M
Capital Expenditures	$920.9K	$30.99K	$540.4K
Free Cash Flow	-$7.921M	-$5.436M	-$25.64M
YoY Change	-5.42%	-6.52%	15.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28426616
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36668980
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001682639
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38365
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1614104
CY2022	dei	Entity Registrant Name EntityRegistrantName	EYENOVIA, INC.
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1178401
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	295 Madison Avenue
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2400
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	NEW YORK
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
CY2022	dei	City Area Code CityAreaCode	833
CY2022	dei	Local Phone Number LocalPhoneNumber	393-6684
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 Par Value
CY2022	dei	Trading Symbol TradingSymbol	EYEN
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q2	dei	Entity Public Float EntityPublicFloat	53095760
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37991746
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22863520
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19461850
CY2022Q4	eyen	Deferred Clinical Supply Costs DeferredClinicalSupplyCosts	2284931
CY2022Q4	eyen	License Fee And Expense Reimbursements Receivables LicenseFeeAndExpenseReimbursementsReceivables	1183786
CY2021Q4	eyen	License Fee And Expense Reimbursements Receivables LicenseFeeAndExpenseReimbursementsReceivables	1805065
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	119550
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1190719
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	734942
CY2022Q4	us-gaap	Assets Current AssetsCurrent	27642506
CY2021Q4	us-gaap	Assets Current AssetsCurrent	22001857
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	7875000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1295115
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1271225
CY2022Q4	eyen	Security Deposits SecurityDeposits	80874
CY2021Q4	eyen	Security Deposits SecurityDeposits	119035
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1291592
CY2022Q4	eyen	Equipment Deposits EquipmentDeposits	726326
CY2021Q4	eyen	Equipment Deposits EquipmentDeposits	391941
CY2022Q4	us-gaap	Assets Assets	31036413
CY2021Q4	us-gaap	Assets Assets	31659058
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1428283
CY2022Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	1747191
CY2021Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	1543618
CY2022Q4	eyen	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	503076
CY2021Q4	eyen	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	845719
CY2021Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	18685
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	484882
CY2022Q4	eyen	Notes Payable Unamortized Discount Current NotesPayableUnamortizedDiscountCurrent	33885
CY2021Q4	eyen	Notes Payable Unamortized Discount Current NotesPayableUnamortizedDiscountCurrent	349632
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	174448
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	7150368
CY2022Q4	eyen	Convertible Notes Payable Unamortized Discount Current ConvertibleNotesPayableUnamortizedDiscountCurrent	33885
CY2021Q4	eyen	Convertible Notes Payable Unamortized Discount Current ConvertibleNotesPayableUnamortizedDiscountCurrent	0
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	174448
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4512328
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11172494
CY2021Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	19949
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	907644
CY2022Q4	eyen	Notes Payable Unamortized Discount Noncurrent NotesPayableUnamortizedDiscountNoncurrent	813229
CY2021Q4	eyen	Notes Payable Unamortized Discount Noncurrent NotesPayableUnamortizedDiscountNoncurrent	0
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	4190938
CY2022Q4	eyen	Convertible Notes Payable Unamortized Discount Noncurrent ConvertibleNotesPayableUnamortizedDiscountNoncurrent	813229
CY2021Q4	eyen	Convertible Notes Payable Unamortized Discount Noncurrent ConvertibleNotesPayableUnamortizedDiscountNoncurrent	0
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	4190938
CY2022Q4	us-gaap	Liabilities Liabilities	13801848
CY2021Q4	us-gaap	Liabilities Liabilities	11192443
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36668980
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28426616
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3667
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2844
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	135461361
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	110683077
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-118230463
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-90219306
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17234565
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20466615
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31036413
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31659058
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14000000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1600000
CY2021	us-gaap	Gross Profit GrossProfit	12400000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13378680
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14850874
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13532835
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10569653
CY2022	us-gaap	Operating Expenses OperatingExpenses	26911515
CY2021	us-gaap	Operating Expenses OperatingExpenses	25420527
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-26911515
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-13020527
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	463353
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	197090
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	164027
CY2022	us-gaap	Interest Expense InterestExpense	1380058
CY2021	us-gaap	Interest Expense InterestExpense	387756
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	83326
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2516
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28011157
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12778387
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33649747
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33649747
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26324081
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26324081
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	15303885
CY2021	eyen	Stock Issued At Market Offering During Period Value New Issues StockIssuedAtMarketOfferingDuringPeriodValueNewIssues	12401919
CY2021	eyen	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2124904
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	203126
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	26324
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	351390
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2886102
CY2021	eyen	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12778387
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20466615
CY2022	eyen	Stock Issued During Period Value New Issues One StockIssuedDuringPeriodValueNewIssuesOne	14897908
CY2022	eyen	Stock Issued During Period Value Debt Financing StockIssuedDuringPeriodValueDebtFinancing	859733
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	44375
CY2022	eyen	Stock Issued At Market Offering During Period Value New Issues StockIssuedAtMarketOfferingDuringPeriodValueNewIssues	5281776
CY2022	eyen	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	18701
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3765364
CY2022	eyen	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28011157
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17234565
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	354539
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3149
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28011157
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12778387
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3765364
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2886102
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	307430
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	221563
CY2022	eyen	Amortization Of Debt Discount AmortizationOfDebtDiscount	411918
CY2021	eyen	Amortization Of Debt Discount AmortizationOfDebtDiscount	68376
CY2022	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	209040
CY2021	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	463353
CY2022	eyen	Non Cash Rent Expense NonCashRentExpense	474778
CY2021	eyen	Non Cash Rent Expense NonCashRentExpense	0
CY2022	eyen	Expense Reimbursement ExpenseReimbursement	0
CY2021	eyen	Expense Reimbursement ExpenseReimbursement	51588
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	55194
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-219555
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-423896
CY2022	eyen	Increase Decrease In License Fee And Expense Reimbursements Receivables IncreaseDecreaseInLicenseFeeAndExpenseReimbursementsReceivables	-621279
CY2021	eyen	Increase Decrease In License Fee And Expense Reimbursements Receivables IncreaseDecreaseInLicenseFeeAndExpenseReimbursementsReceivables	-1397924
CY2022	eyen	Increase Decrease In Deferred Clinical Supply Costs IncreaseDecreaseInDeferredClinicalSupplyCosts	2284931
CY2021	eyen	Increase Decrease In Deferred Clinical Supply Costs IncreaseDecreaseInDeferredClinicalSupplyCosts	0
CY2022	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0
CY2021	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-1600000
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-81389
CY2021	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	0
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-185821
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	126115
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	203573
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	392946
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-342643
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-634973
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-14000000
CY2022	eyen	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	0
CY2021	eyen	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-7859
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-412478
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25105482
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20874432
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	540360
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1226576
CY2022	eyen	Vendor Deposits For Property Plant And Equipment VendorDepositsForPropertyPlantAndEquipment	334385
CY2021	eyen	Vendor Deposits For Property Plant And Equipment VendorDepositsForPropertyPlantAndEquipment	391941
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-874745
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1618517
CY2022	eyen	Proceeds From Sale Of Common Stock And Warrants In Registered Direct Offering ProceedsFromSaleOfCommonStockAndWarrantsInRegisteredDirectOffering	14981299
CY2021	eyen	Proceeds From Sale Of Common Stock And Warrants In Registered Direct Offering ProceedsFromSaleOfCommonStockAndWarrantsInRegisteredDirectOffering	0
CY2022	eyen	Payments Of Stock Issuance Costs Registered Direct Offering PaymentsOfStockIssuanceCostsRegisteredDirectOffering	83391
CY2021	eyen	Payments Of Stock Issuance Costs Registered Direct Offering PaymentsOfStockIssuanceCostsRegisteredDirectOffering	0
CY2022	eyen	Proceeds From Issuance Of Common Stock At Market Offering ProceedsFromIssuanceOfCommonStockAtMarketOffering	5445130
CY2021	eyen	Proceeds From Issuance Of Common Stock At Market Offering ProceedsFromIssuanceOfCommonStockAtMarketOffering	12785483
CY2022	eyen	Payments Of Stock Issuance Costs At Market Offering PaymentsOfStockIssuanceCostsAtMarketOffering	163354
CY2021	eyen	Payments Of Stock Issuance Costs At Market Offering PaymentsOfStockIssuanceCostsAtMarketOffering	383564
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	18701
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2124904
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	7500000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	66618
CY2022	eyen	Proceeds From Issuance Of Debt And Equity Related Party ProceedsFromIssuanceOfDebtAndEquityRelatedParty	10000000
CY2021	eyen	Proceeds From Issuance Of Debt And Equity Related Party ProceedsFromIssuanceOfDebtAndEquityRelatedParty	0
CY2022	eyen	Payments Of Stock Issuance Costs Related Party PaymentsOfStockIssuanceCostsRelatedParty	46836
CY2021	eyen	Payments Of Stock Issuance Costs Related Party PaymentsOfStockIssuanceCostsRelatedParty	0
CY2022	eyen	Payments Of Debt Issuance Costs Related Party PaymentsOfDebtIssuanceCostsRelatedParty	469320
CY2021	eyen	Payments Of Debt Issuance Costs Related Party PaymentsOfDebtIssuanceCostsRelatedParty	0
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	8175332
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	705360
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	203126
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21506897
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21457971
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4473330
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1034978
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27336850
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28371828
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22863520
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27336850
CY2022	eyen	Proceeds Of Stock Issued During Period Gross ProceedsOfStockIssuedDuringPeriodGross	14981299
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22863520
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19461850
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7875000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22863520
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27336850
CY2022	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	315550
CY2021	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	227171
CY2022	eyen	Purchase Of Insurance Premium Financed By Short Term Note Payable PurchaseOfInsurancePremiumFinancedByShortTermNotePayable	675332
CY2021	eyen	Purchase Of Insurance Premium Financed By Short Term Note Payable PurchaseOfInsurancePremiumFinancedByShortTermNotePayable	705360
CY2022	eyen	Recognition Of Right Of Use Asset For Lease Liability Upon Adoption Of Accounting Standard Update RecognitionOfRightOfUseAssetForLeaseLiabilityUponAdoptionOfAccountingStandardUpdate	618906
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1186098
CY2021	eyen	Shares Withheld From Option Exercise For Employee Tax Liability SharesWithheldFromOptionExerciseForEmployeeTaxLiability	26324
CY2021	eyen	Warrants Issued For Debt Issuance Costs WarrantsIssuedForDebtIssuanceCosts	351390
CY2022Q4	eyen	Common Stocks Discount On Shares CommonStocksDiscountOnShares	859733
CY2022	eyen	Issuance Of Common Stock Related To Vested Restricted Stock Units IssuanceOfCommonStockRelatedToVestedRestrictedStockUnits	11
CY2021	eyen	Issuance Of Common Stock Related To Vested Restricted Stock Units IssuanceOfCommonStockRelatedToVestedRestrictedStockUnits	2
CY2022Q4	eyen	Accrued Leasehold Improvements Current AccruedLeaseholdImprovementsCurrent	92528
CY2022	eyen	Percentage Of Success Rate Of Optejet PercentageOfSuccessRateOfOptejet	0.98
CY2022	eyen	Percentage Of Successful Rate Of Traditional Eye Drops PercentageOfSuccessfulRateOfTraditionalEyeDrops	0.50
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22900000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-118200000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28000000.0
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12800000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25100000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20900000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;">Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and the amounts disclosed in the related notes to the financial statements. The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">reported in the Company’s balance sheets and the amounts of expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, fair value calculations for equity securities, establishment of valuation allowances for deferred tax assets, revenue recognition, the recoverability and useful lives of long-lived assets, the recovery of deferred costs and the deferral of revenues. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 2 - Summary of Significant Accounting Policies — Stock-Based Compensation for additional discussion of the use of estimates in estimating the fair value of the Company’s common stock. </p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain prior period balances have been reclassified in order to conform to current period presentation. These reclassifications have no effect on previously reported results of operations or loss per share.</p>
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7875000
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	22613520
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	22613520
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	19211850
CY2021Q4	eyen	Accrued Leasehold Improvements Current AccruedLeaseholdImprovementsCurrent	0
CY2022Q4	eyen	Credit Card Payable CreditCardPayable	50639
CY2021Q4	eyen	Credit Card Payable CreditCardPayable	20000
CY2022Q4	eyen	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	35524
CY2021Q4	eyen	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	436840
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4385
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	42407
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	94792
CY2022Q4	eyen	Accrued Franchise Tax AccruedFranchiseTax	0
CY2021Q4	eyen	Accrued Franchise Tax AccruedFranchiseTax	1680
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28011157
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12778387
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28011157
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12778387
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	33252644
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	26238134
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	333037
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	64066
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	85947
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33649747
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33649747
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26324081
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26324081
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11641198
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5636891
CY2022	eyen	Deferred Rent Derecognizing Amount DeferredRentDerecognizingAmount	39000
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	503076
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	845719
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	633151
CY2022Q4	eyen	Payroll Taxes Receivable PayrollTaxesReceivable	660891
CY2021Q4	eyen	Payroll Taxes Receivable PayrollTaxesReceivable	343785
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	201082
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	171370
CY2022Q4	eyen	Prepaid Conference Expenses PrepaidConferenceExpenses	97743
CY2021Q4	eyen	Prepaid Conference Expenses PrepaidConferenceExpenses	12586
CY2022Q4	eyen	Prepaid General And Administrative Expenses PrepaidGeneralAndAdministrativeExpenses	87982
CY2021Q4	eyen	Prepaid General And Administrative Expenses PrepaidGeneralAndAdministrativeExpenses	71375
CY2022Q4	eyen	Prepaid Rent And Security Deposit PrepaidRentAndSecurityDeposit	74959
CY2021Q4	eyen	Prepaid Rent And Security Deposit PrepaidRentAndSecurityDeposit	32254
CY2022Q4	eyen	Prepaid Patent Expense PrepaidPatentExpense	38796
CY2021Q4	eyen	Prepaid Patent Expense PrepaidPatentExpense	32797
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	26745
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4525
CY2022Q4	eyen	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	2521
CY2021Q4	eyen	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	0
CY2022Q4	eyen	Prepaid Director Fees Current PrepaidDirectorFeesCurrent	0
CY2021Q4	eyen	Prepaid Director Fees Current PrepaidDirectorFeesCurrent	66250
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1190719
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	734942
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.013
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.038
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.203
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.282
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	531454
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1930953
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1599633
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	635838
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	328408
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1295115
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1271225
CY2022Q4	eyen	Accrued Consulting And Professional Services Current AccruedConsultingAndProfessionalServicesCurrent	320000
CY2021Q4	eyen	Accrued Consulting And Professional Services Current AccruedConsultingAndProfessionalServicesCurrent	250000
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1447643
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1245795
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	299548
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	297823
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1747191
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1543618
CY2022Q4	us-gaap	Notes Payable NotesPayable	10425000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1694228
CY2022Q4	eyen	Notes Payable Net Of Debt Discount Total NotesPayableNetOfDebtDiscountTotal	8730772
CY2021Q4	us-gaap	Notes Payable NotesPayable	7500000
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	349632
CY2021Q4	eyen	Notes Payable Net Of Debt Discount Total NotesPayableNetOfDebtDiscountTotal	7150368
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	10008334
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	1626458
CY2022Q4	eyen	Notes Payable Non Current Net Of Debt Discount Non Current Non Current Portion NotesPayableNonCurrentNetOfDebtDiscountNonCurrentNonCurrentPortion	8381876
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	4190938
CY2022Q4	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8025000
CY2022Q4	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	7500000
CY2022Q4	eyen	Debt Instrument Final Payment DebtInstrumentFinalPayment	-375000
CY2022Q4	eyen	Percentage Of Prepayment Fees PercentageOfPrepaymentFees	0.02
CY2022Q4	eyen	Prepayment Fees Amount PrepaymentFeesAmount	-150000
CY2022Q4	eyen	Restricted Cash Used For Repayment Of Loan RestrictedCashUsedForRepaymentOfLoan	7875000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	20165693
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17415488
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	799182
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	605919
CY2022Q4	eyen	Deferred Tax Assets Capitalized Research And Development Costs DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts	2304110
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2089014
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2070759
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	5879362
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1248043
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-208806
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2358623
CY2022	eyen	Deferred Income Tax Expense Benefit Before Adjustments For Change In Valuation Allowance DeferredIncomeTaxExpenseBenefitBeforeAdjustmentsForChangeInValuationAllowance	5670556
CY2021	eyen	Deferred Income Tax Expense Benefit Before Adjustments For Change In Valuation Allowance DeferredIncomeTaxExpenseBenefitBeforeAdjustmentsForChangeInValuationAllowance	-3606666
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5670556
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-3606666
CY2022	eyen	Effective Income Tax Rate Reconciliation Net At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationNetAtFederalStatutoryIncomeTaxRate	-0.210
CY2021	eyen	Effective Income Tax Rate Reconciliation Net At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationNetAtFederalStatutoryIncomeTaxRate	-0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.025
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.073
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.016
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.043
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.010
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.006
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.013
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.002
CY2022Q4	eyen	Deferred Tax Assets Lease Liabilitites DeferredTaxAssetsLeaseLiabilitites	327276
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	26318426
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20623620
CY2022Q4	eyen	Deferred Tax Assets Liability Property And Equipment DeferredTaxAssetsLiabilityPropertyAndEquipment	184138
CY2021Q4	eyen	Deferred Tax Assets Liability Property And Equipment DeferredTaxAssetsLiabilityPropertyAndEquipment	463442
CY2022Q4	eyen	Deferred Tax Liabilities Rights Of Use Assets DeferredTaxLiabilitiesRightsOfUseAssets	-303554
CY2022Q4	eyen	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	25830734
CY2021Q4	eyen	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	20160178
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25830734
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20160178
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5670556
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-3606666
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	85900000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	10800000
CY2022	eyen	Operating Loss Carry Forwards Expiration Term OperatingLossCarryForwardsExpirationTerm	2034 to 2037
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	75100000
CY2022Q4	eyen	Net Operating Loss Limit For Utilization As Per Internal Revenue Code NetOperatingLossLimitForUtilizationAsPerInternalRevenueCode	35000000
CY2022Q4	eyen	Net Operating Loss Annual Utilization Limit As Per Internal Revenue Code NetOperatingLossAnnualUtilizationLimitAsPerInternalRevenueCode	918000
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	412478
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1186098
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M15D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.100
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	588181
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	278254
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	289887
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	302039
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	216126
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1674487
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	281961
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1392526
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	484882
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	907644
CY2020Q2	eyen	Percentage Of Royalty To Be Transferred Range2 PercentageOfRoyaltyToBeTransferredRange2	0.40
CY2020Q2	eyen	Percentage Of Royalty To Be Transferred Range1 PercentageOfRoyaltyToBeTransferredRange1	0.30
CY2020Q2	eyen	Percentage Of Royalty To Be Transferred Range2 PercentageOfRoyaltyToBeTransferredRange2	0.40
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1217715
CY2021Q4	eyen	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	2.69
CY2022	eyen	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted	6740260
CY2022	eyen	Class Of Warrant Or Right Granted Weighted Average Exercise Price ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice	2.56
CY2022	eyen	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	-1870130
CY2022	eyen	Class Of Warrant Or Right Exercised Weighted Average Exercise Price ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice	0.01
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6087845
CY2022Q4	eyen	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	3.37
CY2022	eyen	Class Of Warrant Or Right Outstanding Weighted Average Remaining Life ClassOfWarrantOrRightOutstandingWeightedAverageRemainingLife	P4Y3M18D
CY2022Q4	eyen	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	6087845
CY2022Q4	eyen	Class Of Warrant Or Right Exercisable Weighted Average Exercise Price ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice	3.37
CY2022	eyen	Class Of Warrant Or Right Exercisable Weighted Average Remaining Life ClassOfWarrantOrRightExercisableWeightedAverageRemainingLife	P4Y3M18D
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6087845
CY2022	eyen	Class Of Warrant Or Right Exercisable Weighted Average Remaining Life ClassOfWarrantOrRightExercisableWeightedAverageRemainingLife	P4Y3M18D
CY2022Q4	eyen	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	6087845
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1870130
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	18701
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3765364
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2886102
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	41778
CY2021Q4	eyen	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Non Vested Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsNonVestedOutstandingWeightedAverageExercisePrice	3.59
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	193304
CY2022	eyen	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice	1.93
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	55319
CY2022	eyen	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice	3.37
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	6963
CY2022	eyen	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	3.59
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	172800
CY2022Q4	eyen	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Non Vested Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsNonVestedOutstandingWeightedAverageExercisePrice	1.80
CY2022	eyen	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested Rs Us Undelivered Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedRSUsUndeliveredNumber	32900
CY2022	eyen	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested Rs Us Undelivered Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedRSUsUndeliveredWeightedAverageExercisePrice	3.59
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	5380553
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y4M24D
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	3614195
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.60
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.39
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3621440
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y6M
CY2019Q2	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1
CY2019Q2	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.04
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	208006
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	175352

Files In Submission

Name	View Source	Status
0001410578-23-000511-index-headers.html	Edgar Link	pending
0001410578-23-000511-index.html	Edgar Link	pending
0001410578-23-000511.txt	Edgar Link	pending
0001410578-23-000511-xbrl.zip	Edgar Link	pending
eyen-20221231.xsd	Edgar Link	pending
eyen-20221231x10k.htm	Edgar Link	pending
eyen-20221231x10k002.jpg	Edgar Link	pending
eyen-20221231x10k003.jpg	Edgar Link	pending
eyen-20221231x10k004.jpg	Edgar Link	pending
eyen-20221231x10k006.jpg	Edgar Link	pending
eyen-20221231x10k007.jpg	Edgar Link	pending
eyen-20221231x10k008.jpg	Edgar Link	pending
eyen-20221231x10k009.jpg	Edgar Link	pending
eyen-20221231x10k010.jpg	Edgar Link	pending
eyen-20221231x10k011.jpg	Edgar Link	pending
eyen-20221231x10k012.jpg	Edgar Link	pending
eyen-20221231x10k013.jpg	Edgar Link	pending
eyen-20221231x10k014.jpg	Edgar Link	pending
eyen-20221231x10k015.jpg	Edgar Link	pending
eyen-20221231x10k016.jpg	Edgar Link	pending
eyen-20221231x10k017.jpg	Edgar Link	pending
eyen-20221231x10k018.jpg	Edgar Link	pending
eyen-20221231x10k019.jpg	Edgar Link	pending
eyen-20221231xex10d30.htm	Edgar Link	pending
eyen-20221231xex10d31.htm	Edgar Link	pending
eyen-20221231xex10d32.htm	Edgar Link	pending
eyen-20221231xex10d33.htm	Edgar Link	pending
eyen-20221231xex23d1.htm	Edgar Link	pending
eyen-20221231xex31d1.htm	Edgar Link	pending
eyen-20221231xex31d2.htm	Edgar Link	pending
eyen-20221231xex32d1.htm	Edgar Link	pending
eyen-20221231xex32d2.htm	Edgar Link	pending
eyen-20221231xex4d1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
eyen-20221231_lab.xml	Edgar Link	unprocessable
eyen-20221231_cal.xml	Edgar Link	unprocessable
eyen-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
eyen-20221231_def.xml	Edgar Link	unprocessable
eyen-20221231x10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EYEN
EYENOVIA, INC. Stock $eyen

2023 Q1 Form 10-K Financial Statement

#000141057823000511 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EYEN EYENOVIA, INC. Stock $eyen

2023 Q1 Form 10-K Financial Statement

#000141057823000511 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EYEN
EYENOVIA, INC. Stock $eyen